Nordic pharmaceutical market growth slowed down slightly during February–April 2009. The higher than expected growth (6%) in Denmark results from substantial deliveries to hospitals and does not represent the development in private pharmacies.
In the Baltic region, the double-digit market growth has come to an end after many years. The economic slowdown has strongly impacted consumer demand and pharmaceutical sales have declined considerably.
In Poland, the steady pharmaceutical market growth continued during first quarter.
